U.S. market Closed. Opens in 1 day 5 hours 2 minutes

PTCT | PTC Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
Revenue937.82M698.80M538.59M380.77M306.98M264.73M194.39M82.70M36.77M22.96M31.33M28.78M98.96M
Cost of Revenue65.49M44.68M32.33M18.94M12.13M12.67M4.58M117.63M121.82M79.84M54.88M-5.17MN/A
Gross Profit872.34M654.12M506.26M361.82M294.85M252.06M189.81M-34.93M-85.05M-56.88M-23.55M33.95M98.96M
Operating Expenses1.31B1.09B881.21M759.70M487.64M348.41M254.11M214.76M203.90M122.38M76.72M55.59M68.38M
Selling, General & Admin332.54M326.00M285.77M245.16M202.54M153.55M121.27M97.13M82.08M44.82M25.22M14.62M16.15M
Research & Development666.56M651.50M540.68M477.64M257.45M171.98M117.46M117.63M121.82M79.84M54.88M46.14M58.68M
Other Operating ExpensesN/A116.55M54.75M36.89M27.65M129.00K-1.28M-1.21M-465.00K-213.00K37.51K1.78M461.36K
Operating Income-349.40M-439.93M-374.94M-397.88M-192.80M-115.69M-64.29M-132.06M-167.13M-99.41M-45.40M-26.81M30.58M
Other Expenses / Income-346.71M-147.56M-143.40M-59.36M-47.13M-12.43M-13.37M-9.48M-2.83M967.00K-6.18M573.00K-1.98M
Before Tax Income-696.11M-587.49M-518.34M-402.93M-239.93M-128.11M-77.67M-141.54M-169.96M-98.45M-51.57M-26.24M28.60M
Income Tax Expenses-69.51M-28.47M5.56M35.23M11.65M-29.00K1.33M569.00K485.00K-4.69M6.21M1.21M-2.31M
Net Income-626.60M-559.02M-523.90M-438.16M-251.58M-128.08M-79.00M-142.11M-170.45M-93.75M-51.57M-26.24M30.90M
Interest Expenses129.18M90.87M86.02M56.35M12.49M12.55M12.09M8.28M2.37M1.18MN/AN/A2.44M
Basic Shares Outstanding74.84M71.73M70.47M66.03M58.86M46.58M39.11M34.04M33.62M31.57M12.82M14.19M14.19M
Diluted Shares Outstanding74.84M71.73M70.47M66.03M58.86M46.58M39.18M34.04M33.63M31.57M12.83M23.68M23.68M
EBITDA-330.34M-367.78M-374.44M-297.00M-191.38M-89.47M-46.61M-128.77M-164.25M-97.18M-43.00M-24.10M33.45M
EBITDA Margin-35.22%-52.63%-69.52%-78.00%-62.34%-33.80%-23.98%-155.70%-446.76%-423.19%-137.27%-83.76%33.80%
EBIT-566.93M-496.62M-432.32M-346.58M-227.44M-115.56M-65.57M-133.26M-167.59M-97.27M-45.36M-25.03M31.04M
EBIT Margin-60.45%-71.07%-80.27%-91.02%-74.09%-43.65%-33.73%-161.13%-455.84%-423.58%-144.80%-86.96%31.37%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙